NanoViricides, Inc.
NNVC
$1.43
$0.096.72%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 39.38% | 47.77% | 118.57% | 58.41% | 12.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.86% | -5.75% | 55.93% | -34.95% | 5.40% |
| Operating Income | -17.86% | 5.75% | -55.93% | 34.95% | -5.40% |
| Income Before Tax | -19.54% | 4.13% | -58.83% | 34.01% | -8.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.54% | 4.13% | -58.83% | 34.01% | -8.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.54% | 4.13% | -58.83% | 34.01% | -8.91% |
| EBIT | -17.86% | 5.75% | -55.93% | 34.95% | -5.40% |
| EBITDA | -19.76% | 6.63% | -61.31% | 36.89% | -5.92% |
| EPS Basic | 12.13% | 22.77% | -35.71% | 37.09% | -7.59% |
| Normalized Basic EPS | 12.09% | 22.67% | -35.71% | 37.08% | -7.54% |
| EPS Diluted | 12.13% | 22.77% | -35.71% | 37.09% | -7.59% |
| Normalized Diluted EPS | 12.09% | 22.67% | -35.71% | 37.08% | -7.54% |
| Average Basic Shares Outstanding | 36.05% | 24.06% | 17.04% | 4.92% | 1.23% |
| Average Diluted Shares Outstanding | 36.05% | 24.06% | 17.04% | 4.92% | 1.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |